Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Liu, Jiaa; 1; 2 | Wang, Qianqiana; 1 | Jing, Donglaia | Gao, Rana | Zhang, Jinga | Cui, Chunleib | Qiao, Hongwenb | Liang, Zhigangb | Wang, Chaodonga; d | Rosa-Neto, Pedroc | Wu, Liyonga; d; * | Jia, Jianpinga | Gauthier, Sergec
Affiliations: [a] Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China | [b] Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China | [c] Alzheimer’s Disease Research Unit, McGill Centre for Studies in Aging, Canada | [d] National Clinical Research Center for Geriatric Disorders, Capital Medical University, Beijing, China
Correspondence: [*] Correspondence to: Dr. Liyong Wu, Department of Neurology, Xuanwu hospital, Capital Medical University, Changchun Street 45, Beijing 100053, China. E-mail: wmywly@hotmail.com.
Note: [1] These authors contributed equally to this work.
Note: [2] ORCID ID for Dr. Jia Liu: https://orcid.org/0000-0002-6150-8305.
Abstract: For early-onset Alzheimer’s disease (EOAD) cases with unclear family history, most cases are sporadic. Some cases are positive in genetic findings, that is, either incomplete penetrance or de novo mutation. We aimed to focus on EOAD cases with de novo mutations. Case reports and literature review were performed. The implication for diagnostic approach of early-onset dementia with negative family history was developed. We reported two Chinese EOAD cases with de novo mutations. The genotype PSEN1 G206S appeared to correlate with the phenotype of EOAD with pure cognitive problems. The second case had a PSEN1 M233V mutation with an earlier age of onset of 25 with cognitive decline, parkinsonism, and epilepsy. Although EOAD due to de novo mutations is not common, it should be considered in patients with a phenotype of progressive cognitive decline and amyloid positivity on PET or CSF analysis.
Keywords: De novo PSEN1 mutation, diagnostic approach, early-onset Alzheimer’s disease, early-onset dementia with negative family history
DOI: 10.3233/JAD-181108
Journal: Journal of Alzheimer's Disease, vol. 68, no. 2, pp. 551-558, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl